Firefly Neuroscience Partners With U.S. Military to Revolutionize Brain Injury Care
Firefly Neuroscience has teamed up with the U.S. Department of War to tackle brain health issues among military personnel. The partnership will focus on diagnosing and monitoring treatment for PTSD and traumatic brain injury (TBI) using AI-driven EEG technology. Both conditions pose major challenges for service members and veterans, with high costs and widespread impact. The collaboration builds on earlier work with the U.S. Naval Medical Center Camp Lejeune's Family Medicine Residency program. Firefly's FDA-cleared platform uses EEG and AI to deliver objective, data-driven insights into brain function. This non-invasive system is designed for large-scale use in real-world medical settings.
PTSD and TBI affect military populations at disproportionate rates. Over 444,300 U.S. service members received at least one TBI diagnosis between 2000 and 2021. The economic burden of PTSD alone reaches $232.2 billion nationwide, with $42.7 billion tied directly to military cases.
Firefly's technology is already being applied across related defence health initiatives. The platform provides military healthcare providers with quantitative neurological data to guide treatment decisions. Dave DeCaprio, Firefly's President and COO, stated that the partnership aligns with the company's mission to expand access to advanced brain health tools.
Greg Lipschitz, Firefly's CEO, highlighted the strategic importance of the deal. He noted that growing U.S. government investment in military brain health creates a significant opportunity for the company. The agreement also marks a key step in Firefly's commercial strategy, opening doors to broader government and defence health contracts. The partnership will support active-duty personnel and veterans through improved diagnostics and monitoring. Firefly's scalable EEG platform aims to provide faster, more accurate assessments for PTSD and TBI. While specific military sites using the technology remain undisclosed, the initiative reflects a broader push to modernise brain health care within the armed forces.
